Gene regulation by histone-modifying enzymes under hypoxic conditions: a focus on histone methylation and acetylation

참고문헌 (124)

1. Kindrick, J. D., "Hypoxic regulation of gene transcription and chromatin : cause and effect", Int. J. Mol. Sci, 21, pp.8320~ (2020)
2. Hancock, R. L., "Epigenetic regulation by histone demethylases in hypoxia", Epigenomics, 7, pp.791~811 (2015)
3. Batie, M., "Hypoxia and chromatin : a focus on transcriptional repression mechanisms", Biomedicines, 6, pp.47~ (2018)
4. Majmundar, A. J., "Hypoxia-inducible factors and the response to hypoxic stress", Mol. Cell, 40, pp.294~309 (2010)
5. Lee, P., "Cellular adaptation to hypoxia through hypoxia inducible factors and beyond", Nat. Rev. Mol. Cell Biol, 21, pp.268~283 (2020)
6. Islam, M. S., "2-Oxoglutarate-dependent oxygenases", Annu. Rev. Biochem, 87, pp.585~620 (2018)
7. Frost, J., "Roles of HIF and 2-oxoglutaratedependent dioxygenases in controlling gene expression in hypoxia", Cancers(Basel), 13, pp.350~ (2021)
8. Hewitson, K. S., "Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family", J. Biol. Chem, 277, pp.26351~26355 (2002)
9. Cutter, A. R., "A brief review of nucleosome structure", FEBS Lett, 589, pp.2914~2922 (2015)
10. Venkatesh, S., "Histone exchange, chromatin structure and the regulation of transcription", Nat. Rev. Mol. Cell Biol, 16, pp.178~189 (2015)
11. Clapier, C. R., "The biology of chromatin remodeling complexes", Annu. Rev. Biochem, 78, pp.273~304 (2009)
12. Bannister, A. J., "Regulation of chromatin by histone modifications", Cell Res, 21, pp.381~395 (2011)
13. 이선주, "Histone tail cleavage as a novel epigenetic regulatory mechanism for gene expression", BMB Reports, 51(5), pp.211~218 (2018), 생화학분자생물학회
14. Albanese, A., "The role of hypoxia-inducible factor post-translational modifications in regulating its localisation, stability, and activity", Int. J. Mol. Sci, 22, pp.268~ (2020)
15. Yi, S. J., "Bone remodeling: histone modifications as fate determinants of bone cell differentiation", Int. J. Mol. Sci, 20, pp.3147~ (2019)
16. 현광범, "Writing, erasing and reading histone lysine methylations", Experimental and Molecular Medicine, 49, pp.1~22 (2017), 생화학분자생물학회
17. Yang, Q., "Epigenetics in ovarian cancer: premise, properties, and perspectives", Mol. Cancer, 17, pp.109~ (2018)
18. D’Oto, A., "Histone demethylases and their roles in cancer epigenetics", J. Med. Oncol. Ther, 1, pp.34~40 (2016)
19. Herz, H. M., "SET for life: biochemical activities and biological functions of SET domain-containing proteins", Trends Biochem. Sci, 38, pp.621~639 (2013)
20. Chopra, A., "Hypoxia-inducible lysine methyltransferases : G9a and GLP hypoxic regulation, non-histone substrate modification, and pathological relevance", Front. Genet, 11, pp.579636~ (2020)
21. Lee, J. S., "Negative regulation of hypoxic responses via induced Reptin methylation", Mol. Cell, 39, pp.71~85 (2010)
22. Lee, J. S., "Hypoxia-induced methylation of a pontin chromatin remodeling factor", Proc. Natl Acad. Sci. USA, 108, pp.13510~13515 (2011)
23. Bao, L., "Methylation of hypoxia-inducible factor(HIF)-1alpha by G9a", GLP inhibits HIF-1 transcriptional activity and cell migration, 2018, pp.46, 6576~6591
24. Casciello, F., "G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis", Proc. Natl Acad. Sci. USA, 114, pp.7077~7082 (2017)
25. Heddleston, J. M., "Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential", Cell Death Differ, 19, pp.428~439 (2012)
26. Ortmann, B. M., "The HIF complex recruits the histone methyltransferase SET1B to activate specific hypoxia-inducible genes", Nat. Genet, 53, pp.1022~1035 (2021)
27. Chen, S., "Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice", Cancer Lett, 383, pp.73~84 (2016)
28. Wang, X., "A lncRNA coordinates with Ezh2 to inhibit HIF-1alpha transcription and suppress cancer cell adaption to hypoxia", Oncogene, 39, pp.1860~1874 (2020)
29. Liu, X., "Repression of hypoxia-inducible factor alpha signaling by Set7-mediated methylation", Nucleic Acids Res, 43, pp.5081~5098 (2015)
30. Cao, L., "Downregulation of SETD7 promotes migration and invasion of lung cancer cells via JAK2", STAT3 pathway, 2020, pp.45, 1616~1626
31. Kim, Y., "Methylation-dependent regulation of HIF-1alpha stability restricts retinal and tumour angiogenesis", Nat. Commun, 7, pp.10347~ (2016)
32. Cohn, O., "Chromatin associated SETD3 negatively regulates VEGF expression", Sci. Rep, 6, pp.37115~ (2016)
33. Jiang, X., "SETD3 negatively regulates VEGF expression during hypoxic pulmonary hypertension in rats", Hypertens. Res, 41, pp.691~698 (2018)
34. Lee, J. Y., "LSD1 demethylates HIF1alpha to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis", Oncogene, 36, pp.5512~5521 (2017)
35. Sacca, C. D., "Inhibition of lysine-specific demethylase LSD1 induces senescence in Glioblastoma cells through a HIF-1alpha-dependent pathway", Biochim. Biophys. Acta Gene Regul. Mech, 1862, pp.535~546 (2019)
36. Kim, I., "Hypoxia-driven epigenetic regulation in cancer progression : a focus on histone methylation and its modifying enzymes", Cancer Lett, 489, pp.41~49 (2020)
37. Beyer, S., "The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxiainducible factor HIF", J. Biol. Chem, 283, pp.36542~36552 (2008)
38. Wellmann, S., "Hypoxia upregulates the histone demethylase JMJD1A via HIF-1", Biochem. Biophys. Res. Commun, 372, pp.892~897 (2008)
39. Tausendschon, M., "Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity", Cytokine, 53, pp.256~262 (2011)
40. Lee, H. Y., "Hypoxia enhances the expression of prostatespecific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases", Carcinogenesis, 34, pp.2706~2715 (2013)
41. Mimura, I., "Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3(SLC2A3)by cooperative interaction of hypoxia-inducible factor 1 and KDM3A", Mol. Cell. Biol, 32, pp.3018~3032 (2012)
42. Dobrynin, G., "KDM4A regulates HIF-1 levels through H3K9me3", Sci. Rep, 7, pp.11094~ (2017)
43. Hancock, R. L., "The activity of JmjC histone lysine demethylase KDM4A is highly sensitive to oxygen concentrations", ACS Chem. Biol, 12, pp.1011~1019 (2017)
44. Fu, L., "HIF-1alpha-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism", Carcinogenesis, 33, pp.1664~1673 (2012)
45. Luo, W., "Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression", Proc. Natl Acad. Sci. USA, 109, pp.E3367~E3376 (2012)
46. Gallipoli, P., "Histone modifiers are oxygen sensors", Science, 363, pp.1148~1149 (2019)
47. Batie, M., "Hypoxia induces rapid changes to histone methylation and reprograms chromatin", Science, 363, pp.1222~1226 (2019)
48. Zhou, X., "Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase", Cancer Res, 70, pp.4214~4221 (2010)
49. Chakraborty, A. A., "Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate", Science, 363, pp.1217~1222 (2019)
50. Li, Y., "Kdm6A protects against hypoxia-induced cardiomyocyte apoptosis via H3K27me3 demethylation of Ncx gene", J. Cardiovasc. Transl. Res, 12, pp.488~495 (2019)
51. Liu, O. H., "Hypoxia-mediated regulation of histone demethylases affects angiogenesis-associated functions in endothelial cells", Arterioscler. Thromb. Vasc. Biol, 40, pp.2665~2677 (2020)
52. Prickaerts, P., "Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3", Epigenetics Chromatin, 9, pp.46~ (2016)
53. Schneider, A., "Acetyltransferases(HATs)as targets for neurological therapeutics", Neurotherapeutics, 10, pp.568~588 (2013)
54. 박석열, "A short guide to histone deacetylases including recent progress on class II enzymes", Experimental and Molecular Medicine, 52, pp.1~9 (2020), 생화학분자생물학회[DOI]
55. Li, G., "The roles of histone deacetylases and their inhibitors in cancer therapy", Front. Cell Dev. Biol, 8, pp.576946~ (2020)
56. Arany, Z., "An essential role for p300", CBP in the cellular response to hypoxia, 1996, pp.93, 12969~12973
57. Chen, R., "The acetylase", deacetylase couple CREB-binding protein, J. Biol. Chem, pp.2012, 287[DOI]
58. Ruas, J. L., "Complex regulation of the transactivation function of hypoxiainducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein", p300, 2010, pp.285, 2601~2609
59. Geng, H., "HIF1alpha protein stability is increased by acetylation at lysine 709", J. Biol. Chem, 287, pp.35496~35505 (2012)
60. Yin, S., "Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1alpha interaction with cofactors p300", CBP, 2012, pp.18, 6623~6633
61. Lim, J. H., "Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha", Mol. Cell, 38, pp.864~878 (2010)
62. Feng, X., "Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5", Autophagy, 17, pp.723~742 (2021)
63. Perez-Perri, J. I., "The TIP60 complex is a conserved coactivator of HIF1A", Cell Rep, 16, pp.37~47 (2016)
64. Wang, M., "Lack of MOF decreases susceptibility to hypoxia and promotes multidrug resistance in hepatocellular carcinoma via HIF-1alpha", Front. Cell Dev. Biol, 9, pp.718707~ (2021)
65. Kim, M. S., "Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes", Nat. Med, 7, pp.437~443 (2001)
66. Liang, D., "Effects of histone deacetylase inhibitors on HIF-1", Cell Cycle, 5, pp.2430~2435 (2006)
67. Fath, D. M., "Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIFalpha", J. Biol. Chem, 281, pp.13612~13619 (2006)
68. Jeon, H. W., "Inhibition of histone deacetylase attenuates hypoxiainduced migration and invasion of cancer cells via the restoration of RECK expression", Mol. Cancer Ther, 9, pp.1361~1370 (2010)
69. Liu, M., "Hypoxia-induced feedback of HIF-1alpha and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein", Theranostics, 9, pp.4795~4810 (2019)
70. Zhao, B., "HIF-1alpha and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis", Signal Transduct. Target. Ther, 5, pp.118~ (2020)
71. Pluemsampant, S., "Protein kinase CK2is a key activator of histone deacetylase in hypoxia-associated tumors", Int. J. Cancer, 122, pp.333~341 (2008)
72. Chang, C. C., "HDAC2 promotes cell migration", invasion abilities through HIF-1alpha stabilization in human oral squamous cell carcinoma, 2011, pp.40, 567~575
73. Wu, M. Z., "Interplay between HDAC3 and WDR5 is essential for hypoxiainduced epithelial-mesenchymal transition", Mol. Cell, 43, pp.811~822 (2011)
74. Safronova, O. S., "Acute hypoxia affects P-TEFb through HDAC3 and HEXIM1-dependent mechanism to promote gene-specific transcriptional repression", Nucleic Acids Res, 42, pp.8954~8969 (2014)
75. Wang, J., "Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression", J. Cancer, 12, pp.5320~5330 (2021)
76. Qian, D. Z., "Class II histone deacetylases are associated with VHLindependent regulation of hypoxia-inducible factor 1α", Cancer Res, 66, pp.8814~8821 (2006)
77. Geng, H., "HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia", J. Biol. Chem, 286, pp.38095~38102 (2011)
78. Seo, H. W., "Transcriptional activation of hypoxiainducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1", FEBS Lett, 583, pp.55~60 (2009)
79. Chen, S., "AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1alpha and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol", Cell Cycle, 14, pp.2520~2536 (2015)
80. Kong, X., "Histone deacetylase inhibitors induce VHL and ubiquitinindependent proteasomal degradation of hypoxia-inducible factor 1alpha", Mol. Cell. Biol, 26, pp.2019~2028 (2006)
81. Ryu, H. W., "HDAC6 regulates sensitivity to cell death in response to stress and post-stress recovery", Cell Stress Chaperones, 22, pp.253~261 (2017)
82. Zhang, Z., "Increase in HDAC9 suppresses myoblast differentiation via epigenetic regulation of autophagy in hypoxia", Cell Death Dis, 10, pp.552~ (2019)
83. Yoon, H., "Differential roles of Sirt1in HIF-1alpha and HIF-2alpha mediated hypoxic responses", Biochem. Biophys. Res. Commun, 444, pp.36~43 (2014)
84. Ryu, D. R., "Sirt1-hypoxia-inducible factor-1alpha interaction is a key mediator of tubulointerstitial damage in the aged kidney", Aging Cell, 18, pp.e12904~ (2019)
85. Dioum, E. M., "Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1", Science, 324, pp.1289~1293 (2009)
86. Seo, K. S., "SIRT2 regulates tumour hypoxia response by promoting HIF-1alpha hydroxylation", Oncogene, 34, pp.1354~1362 (2015)
87. Kaitsuka, T., "SIRT2 inhibition activates hypoxiainducible factor 1alpha signaling and mediates neuronal survival", Biochem. Biophys. Res. Commun, 529, pp.957~962 (2020)
88. Tseng, A. H., "SIRT3 interactions with FOXO3acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia", Biochem. J, 464, pp.157~168 (2014)
89. Yang, Z., "SIRT6", HIF-1alpha axis promotes papillary thyroid cancer progression by inducing epithelial-mesenchymal transition, 2019, pp.19, 17~
90. Yang, Z., "SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1alpha and reactive oxygen species", Cell Death Dis, 12, pp.77~ (2021)
91. Hubbi, M. E., "Sirtuin-7 inhibits the activity of hypoxia-inducible factors", J. Biol. Chem, 288, pp.20768~20775 (2013)
92. Adriaens, M. E., "Quantitative analysis of ChIP-seq data uncovers dynamic and sustained H3K4me3 and H3K27me3 modulation in cancer cells under hypoxia", Epigenetics Chromatin, 9, pp.48~ (2016)
93. Lee, S., "Multi-dimensional histone methylations for coordinated regulation of gene expression under hypoxia", Nucleic Acids Res, 45, pp.11643~11657 (2017)
94. Batie, M., "Regulation of chromatin accessibility by hypoxia and HIF", Biochem. J, 479, pp.767~786 (2022)
95. Wang, J., "Hypoxia-induced alterations of transcriptome and chromatin accessibility in HL-1 cells", IUBMB Life, 72, pp.1737~1746 (2020)
96. Li, Y., "Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia", Cell Death Dis, 11, pp.102~ (2020)
97. Ward, M. C., "Dynamic effects of genetic variation on gene expression revealed following hypoxic stress in cardiomyocytes", Elife, 10, pp.e57345~ (2021)
98. Xin, J., "Chromatin accessibility landscape and regulatory network of highaltitude hypoxia adaptation", Nat. Commun, 11, pp.4928~ (2020)
99. Chen, P. S., "Pathophysiological implications of hypoxia in human diseases", J. Biomed. Sci, 27, pp.63~ (2020)
100. Jae W. Lee, "Hypoxia signaling in human diseases and therapeutic targets", Experimental and Molecular Medicine, 51, pp.1~13 (2019), 생화학분자생물학회[DOI]
101. Harris, A. L., "Hypoxia-a key regulatory factor in tumour growth", Nat. Rev. Cancer, 2, pp.38~47 (2002)
102. Kang, H. S., "Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer", Sci. Rep, 10, pp.1854~ (2020)
103. Tanaka, S., "Hypoxia and hypoxia-inducible factors in chronic kidney disease", Ren. Replacement Ther, 2, pp.25~ (2016)
104. Tanemoto, F., "Therapies targeting epigenetic alterations in acute kidney injury-to-chronic kidney disease transition", Pharmaceuticals(Basel), 15, pp.123~ (2022)
105. Funk, J. A., "Persistent disruption of mitochondrial homeostasis after acute kidney injury", Am. J. Physiol. Ren. Physiol, 302, pp.F853~F864 (2012)
106. Ha, S. D., "Histone deacetylase 8protects human proximal tubular epithelial cells from hypoxia-mimetic cobaltand hypoxia", reoxygenation-induced mitochondrial fission and cytotoxicity, 2018, pp.8, 11332~
107. Liu, M., "Novel therapeutic targets for hypoxia-related cardiovascular diseases : the role of HIF-1", Front. Physiol, 11, pp.774~ (2020)
108. Abe, H., "The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases", J. Atheroscler. Thromb, 24, pp.884~894 (2017)
109. Gupta, N.A., "Hypoxia Signaling in Cardiovascular Diseases" (2018), IntechOpen
110. Zhang, W., "Epigenetic modifications in cardiovascular aging and diseases", Circ. Res, 123, pp.773~786 (2018)
111. Bustelo, M., "Clinical implications of epigenetic dysregulation in perinatal hypoxic-ischemic brain damage", Front. Neurol, 11, pp.483~ (2020)
112. Xue, H., "Sevoflurane post-conditioning alleviates neonatal rat hypoxicischemic cerebral injury via Ezh2-regulated autophagy", Drug Des. Devel. Ther, 13, pp.1691~1706 (2019)
113. Cox-Limpens, K. E., "Fetal asphyctic preconditioning alters the transcriptional response to perinatal asphyxia", BMC Neurosci, 15, pp.67~ (2014)
114. Cox-Limpens, K. E., "Fetal brain genomic reprogramming following asphyctic preconditioning", BMC Neurosci, 14, pp.61~ (2013)
115. Ziemka-Nalecz, M., "Sodium butyrate, a histone deacetylase inhibitor, exhibits neuroprotective", neurogenic effects in a rat model of neonatal hypoxiaischemia, 2017, pp.54, 5300~5318
116. Kabakus, N., "Protective effects of valproic acid against hypoxic-ischemic brain injury in neonatal rats", J. Child Neurol, 20, pp.582~587 (2005)
117. Faraco, G., "Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain", Mol. Pharmacol, 70, pp.1876~1884 (2006)
118. Kim, H. J., "Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action", J. Pharmacol. Exp. Ther, 321, pp.892~901 (2007)
119. Jaworska, J., "Effect of the HDAC inhibitor, sodium butyrate, on neurogenesis in a rat model of neonatal hypoxiaischemia : potential mechanism of action", Mol. Neurobiol, 56, pp.6341~6370 (2019)
120. Semenza, G. L., "Hypoxia-inducible factors in physiology and medicine", Cell, 148, pp.399~408 (2012)
121. Prabhakar, N. R., "Hypoxia-inducible factors and obstructive sleep apnea", J. Clin. Invest, 130, pp.5042~5051 (2020)
122. Wang, N., "Histone deacetylase 5is an early epigenetic regulator of intermittent hypoxia induced sympathetic nerve activation and blood pressure", Front. Physiol, 12, pp.688322~ (2021)
123. "Intermittent hypoxia enhances the expression of HIF1A by increasing the quantity and catalytic activity of KDM4A-C and demethylating H3K9me3 at the HIF1A locus" (2021)[URL]
124. Qian, D. Z., "Class II histone deacetylases are associated with VHLindependent regulation of hypoxia-inducible factor 1 alpha", Cancer Res, 66, pp.8814~8821 (2006)

관련 논문AI추천